Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).

Wade, A G; Schlaepfer, T E; Andersen, H F; Kilts, C D

Wade, A G; Schlaepfer, T E; Andersen, H F; Kilts, C D.

Affiliation

Wade AG; CPS Clinical Research Centre, Glasgow, United Kingdom. alan@edgehill.demon.co.uk

J Psychiatr Res ; 43(5): 568-75, 2009 Feb.

Article in En | MEDLINE | ID: mdl-18954875

Subject(s)

Antidepressive Agents, Second-Generation/therapeutic use; Antidepressive Agents/therapeutic use; Citalopram/therapeutic use; Depressive Disorder, Major/drug therapy; Paroxetine/therapeutic use; Thiophenes/therapeutic use; Adult; Analysis of Variance; Depressive Disorder, Major/psychology; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance/statistics & numerical data; Predictive Value of Tests; Psychiatric Status Rating Scales/statistics & numerical data; Remission Induction/methods; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiophenes / Citalopram / Paroxetine / Antidepressive Agents, Second-Generation / Depressive Disorder, Major / Antidepressive Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Psychiatr Res Year: 2009 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google